BACKGROUND: Few studies that investigated the associations between breast density and subsequent breast cancer according to tumor characteristics have produced inconclusive findings. We aimed to determine whether the associations between breast density and subsequent breast cancer varied by tumor characteristics. METHODS: We included 1042 postmenopausal women diagnosed with breast cancer between June 1, 1989, and June 30, 2004, and 1794 matched control subjects from the Nurses' Health Study, an ongoing prospective cohort study of 121 701 registered female nurses across the United States. Breast density was estimated from digitized images using computerized techniques. Information on breast cancer risk factors was obtained prospectively from biennial questionnaires before the date of cancer diagnosis for case subjects and matched control subjects. Polychotomous logistic regression was used to assess associations of breast density with tumor subtypes based on invasiveness, histology, size, grade, receptor status, and involvement of lymph nodes. All tests of statistical significance were two-sided. RESULTS: The risk of breast cancer increased progressively with increase in percent breast density (P(trend) < .001). Women with higher breast density (≥50%) showed a 3.39-fold (odds ratio = 3.39, 95% confidence interval = 2.46 to 4.68) increased risk of breast cancer compared with women with lower breast density (<10%). The associations between breast density and breast cancer risk were stronger for in situ compared with invasive tumors (P(heterogeneity) < .01), high-grade compared with low-grade tumors (P(heterogeneity) = .02), larger (>2 cm) compared with smaller (≤2 cm) tumors (P(heterogeneity) < .01), and estrogen receptor-negative compared with estrogen receptor-positive tumors (P(heterogeneity) = .04). There were no differences in associations by tumor histology, involvement of lymph nodes, and progesterone receptor and HER2 status (P(heterogeneity) > .05). CONCLUSIONS: The findings suggest that higher mammographic density is associated with more aggressive tumor characteristics and also with in situ tumors.
BACKGROUND: Few studies that investigated the associations between breast density and subsequent breast cancer according to tumor characteristics have produced inconclusive findings. We aimed to determine whether the associations between breast density and subsequent breast cancer varied by tumor characteristics. METHODS: We included 1042 postmenopausal women diagnosed with breast cancer between June 1, 1989, and June 30, 2004, and 1794 matched control subjects from the Nurses' Health Study, an ongoing prospective cohort study of 121 701 registered female nurses across the United States. Breast density was estimated from digitized images using computerized techniques. Information on breast cancer risk factors was obtained prospectively from biennial questionnaires before the date of cancer diagnosis for case subjects and matched control subjects. Polychotomous logistic regression was used to assess associations of breast density with tumor subtypes based on invasiveness, histology, size, grade, receptor status, and involvement of lymph nodes. All tests of statistical significance were two-sided. RESULTS: The risk of breast cancer increased progressively with increase in percent breast density (P(trend) < .001). Women with higher breast density (≥50%) showed a 3.39-fold (odds ratio = 3.39, 95% confidence interval = 2.46 to 4.68) increased risk of breast cancer compared with women with lower breast density (<10%). The associations between breast density and breast cancer risk were stronger for in situ compared with invasive tumors (P(heterogeneity) < .01), high-grade compared with low-grade tumors (P(heterogeneity) = .02), larger (>2 cm) compared with smaller (≤2 cm) tumors (P(heterogeneity) < .01), and estrogen receptor-negative compared with estrogen receptor-positive tumors (P(heterogeneity) = .04). There were no differences in associations by tumor histology, involvement of lymph nodes, and progesterone receptor and HER2 status (P(heterogeneity) > .05). CONCLUSIONS: The findings suggest that higher mammographic density is associated with more aggressive tumor characteristics and also with in situ tumors.
Authors: Amanda I Phipps; Christopher I Li; Karla Kerlikowske; William E Barlow; Diana S M Buist Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05-25 Impact factor: 4.254
Authors: Karla Kerlikowske; Andrea J Cook; Diana S M Buist; Steve R Cummings; Celine Vachon; Pamela Vacek; Diana L Miglioretti Journal: J Clin Oncol Date: 2010-07-19 Impact factor: 44.544
Authors: Nehmat Houssami; Linn A Abraham; Diana L Miglioretti; Edward A Sickles; Karla Kerlikowske; Diana S M Buist; Berta M Geller; Hyman B Muss; Les Irwig Journal: JAMA Date: 2011-02-23 Impact factor: 56.272
Authors: N F Boyd; J W Byng; R A Jong; E K Fishell; L E Little; A B Miller; G A Lockwood; D L Tritchler; M J Yaffe Journal: J Natl Cancer Inst Date: 1995-05-03 Impact factor: 13.506
Authors: C Byrne; C Schairer; J Wolfe; N Parekh; M Salane; L A Brinton; R Hoover; R Haile Journal: J Natl Cancer Inst Date: 1995-11-01 Impact factor: 13.506
Authors: Rosa Anna DeFilippis; Hang Chang; Nancy Dumont; Joseph T Rabban; Yunn-Yi Chen; Gerald V Fontenay; Hal K Berman; Mona L Gauthier; Jianxin Zhao; Donglei Hu; James J Marx; Judy A Tjoe; Elad Ziv; Maria Febbraio; Karla Kerlikowske; Bahram Parvin; Thea D Tlsty Journal: Cancer Discov Date: 2012-07-09 Impact factor: 39.397
Authors: Lusine Yaghjyan; Akemi Wijayabahu; A Heather Eliassen; Graham Colditz; Bernard Rosner; Rulla M Tamimi Journal: Cancer Causes Control Date: 2020-05-31 Impact factor: 2.506
Authors: Michael S Shawky; Cecilia W Huo; Kara Britt; Erik W Thompson; Michael A Henderson; Andrew Redfern Journal: Breast Cancer Res Treat Date: 2019-06-08 Impact factor: 4.872
Authors: C C Hack; L Häberle; K Geisler; R Schulz-Wendtland; A Hartmann; P A Fasching; M Uder; D L Wachter; S M Jud; C R Loehberg; M P Lux; C Rauh; M W Beckmann; K Heusinger Journal: Geburtshilfe Frauenheilkd Date: 2013-02 Impact factor: 2.915
Authors: Catherine Schairer; Yan Li; Peter Frawley; Barry I Graubard; Robert D Wellman; Diana S M Buist; Karla Kerlikowske; Tracy L Onega; William F Anderson; Diana L Miglioretti Journal: J Natl Cancer Inst Date: 2013-09-18 Impact factor: 13.506